ClassID:

112949

C12Q2600/136 - page 7 - CPC Classification

Classification description:

Oligonucleotides characterized by their use Screening for pharmacological compounds

Recent Application in this class:
#1801
20110190383
2011-08-04

Diagnostic, Prognostic and Therapeutic Uses of MIRs in Adaptive Pathways and/or Disease Pathways

#1802
20110190161
2011-08-04

Methylation Profile of Cancer

#1803
20110190160
2011-08-04

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21

#1804
20110190157
2011-08-04

Biomarkers for Diagnosis and Treatment of Chronic Lymphocytic Leukemia

#1805
20110190155
2011-08-04

MARKER GENES BASED ON AMIODARONE TREATMENT FOR SCREENING OF DRUG INDUCING PULMONARY TOXICITY AND SCREENING METHODS USING THE SAME

#1806
20110189766
2011-08-04

Micrornas and uses thereof

#1807
20110189688
2011-08-04

Methods for detection of the oncogenic T1796A B-Raf mutation

#1808
20110189670
2011-08-04

Circulating Tumor and Tumor Stem Cell Detection Using Genomic Specific Probes

#1809
20110189669
2011-08-04

METHODS OF AIDING IN THE DIAGNOSIS OF PROSTATE CANCER

#1810
20110185440
2011-07-28

CISD2-Knockout Mice and Uses Thereof

#1811
20110185439
2011-07-28

G PROTEIN COUPLED RECEPTORS AND USES THEREOF

#1812
20110184044
2011-07-28

METHODS AND COMPOSITIONS FOR ASSESSMENT OF PULMONARY FUNCTION AND DISORDERS

#1813
20110183336
2011-07-28

Method to Predict Responsiveness of Breast Cancer to Polyamine-Type Chemotherapy

#1814
20110183313
2011-07-28

Genome Wide Visual Identification of Human Co-Factors of HIV-1 Infection

#1815
20110179501
2011-07-21

Methods for reverting methylation by targeting methyltransferases

#1816
20110178154
2011-07-21

GENE EXPRESSION PROFILE THAT PREDICTS OVARIAN CANCER SUBJECT RESPONSE TO CHEMOTHERAPY

#1817
20110177971
2011-07-21

METHOD FOR DIAGNOSING THE STAGE OF A THYROID TUMOR

#1818
20110177970
2011-07-21

METHODS FOR PREDICTING OR MONITORING WHETHER A PATIENT AFFECTED BY A CANCER IS RESPONSIVE TO A TREATMENT WITH A MOLECULE OF THE TAXOID FAMILY

#1819
20110177968
2011-07-21

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P

#1820
20110177967
2011-07-21

Methods and compositions using splicing regulatory proteins involved in tumor suppression

#1821
20110177958
2011-07-21

METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE

#1822
20110177505
2011-07-21

DNA methylation analysis of regulatory T cells through DNA-methylation analysis of the TSDR region of the gene FOXP3

#1823
20110177502
2011-07-21

IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY DISEASE LOCI AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

#1824
20110177096
2011-07-21

USE OF GPR151 MODULATORS FOR THE TREATMENT OF PAIN

#1825
20110177094
2011-07-21

IVIG MODULATION OF CHEMOKINES FOR TREATMENT OF MULTIPLE SCLEROSIS, ALZHEIMER'S DISEASE, AND PARKINSON'S DISEASE

#1826
20110177059
2011-07-21

PSA AND KLK2 AS THERAPEUTIC TARGETS AND MOLECULES INHIBITING PSA AND KLK2

#1827
20110177033
2011-07-21

RAS RESPONSIVE ELEMENT BINDING PROTEIN 1 (RREB1) AS A THERAPEUTIC TARGET FOR THALASSEMIAS AND SICKLE CELL ANEMIA

#1828
20110172928
2011-07-14

MOLECULAR MARKERS FOR CANCER PROGNOSIS

#1829
20110172158
2011-07-14

TARGETS, METHODS, AND REAGENTS FOR DIAGNOSIS AND TREATMENT OF SCHIZOPHRENIA

#1830
20110171646
2011-07-14

MICRORNA EXPRESSION PROFILE ASSOCIATED WITH PANCREATIC CANCER

#1831
20110171631
2011-07-14

Methods of diagnosing endometriosis

#1832
20110166838
2011-07-07

ALGORITHMS FOR OUTCOME PREDICTION IN PATIENTS WITH NODE-POSITIVE CHEMOTHERAPY-TREATED BREAST CANCER

#1833
20110166201
2011-07-07

miRNAs as therapeutic targets in cancer

#1834
20110166041
2011-07-07

Diagnosis/Therapeutic Strategy For Gynecological Cancer by Utilizing Micro-RNA as Biomarker

#1835
20110165567
2011-07-07

Aberrant methylation of C6Orf150 DNA sequences in human colorectal cancer

#1836
20110165178
2011-07-07

DIAGNOSIS OF PROSTATE CANCER

#1837
20110165174
2011-07-07

Alternatively Transcribed Genes Associated with Memory Consolidation

#1838
20110165168
2011-07-07

CIDEA MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#1839
20110160293
2011-06-30

PRMT1 for target genes of cancer therapy and diagnosis

#1840
20110160288
2011-06-30

OIP5 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS

#1841
20110160280
2011-06-30

CANCER-RELATED GENES, CDCA5, EPHA7, STK31 AND WDHD1

#1842
20110160091
2011-06-30

Methods and nucleic acids for analyses of cell proliferative disorders

#1843
20110159518
2011-06-30

Method for the diagnosis of the presence of an ovarian cancer

#1844
20110159510
2011-06-30

USE OF METHYLATED OR UNMETHYLATED LINE-1 DNA AS A CANCER MARKER

#1845
20110159502
2011-06-30

USE OF METHYLATED OR UNMETHYLATED LINE-1 DNA AS A CANCER MARKER

#1846
20110159501
2011-06-30

USE OF METHYLATED OR UNMETHYLATED LINE-1 DNA AS A CANCER MARKER

#1847
20110159496
2011-06-30

MOLECULAR DIAGNOSIS AND CLASSIFICATION OF MALIGNANT MELANOMA

#1848
20110158911
2011-06-30

Methods for Screening for Antibiotic Compounds

#1849
20110154520
2011-06-23

Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives

#1850
20110154517
2011-06-23

DISORDERS OF VASOREGULATION AND METHODS OF DIAGNOSING THEM

#1851
20110154510
2011-06-23

Automated high-content live animal drug screening using

#1852
20110152355
2011-06-23

Method for predicting and detecting tumor metastasis

#1853
20110152106
2011-06-23

CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer

#1854
20110151490
2011-06-23

Compositions for the Detection and Treatment of Colorectal Cancer

#1855
20110151470
2011-06-23

BIOMARKERS FOR ASSESSING RESPONSE TO C-MET TREATMENT

#1856
20110151469
2011-06-23

INTERFERON EPSILON (IFNE1) AS A MARKER FOR TARGETED CANCER THERAPY

#1857
20110151465
2011-06-23

USE OF METHYLATED OR UNMETHYLATED LINE-1 DNA AS A CANCER MARKER

#1858
20110151456
2011-06-23

TEST METHOD FOR TYPE-2 DIABETES USING GENE POLYMORPHISM

#1859
20110151455
2011-06-23

Fish-ribosyn for antibiotic susceptibility testing

#1860
20110151454
2011-06-23

Gene expression markers of tumor resistance to HER2 inhibitor treatment

#1861
20110150775
2011-06-23

GENOMIC APPROACHES TO FETAL TREATMENT AND DIAGNOSIS

#1862
20110150774
2011-06-23

SCREENING FOR MODULATORS OF CES1 AND/OR CES3 FOR THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#1863
20110150772
2011-06-23

MODULATORS OF CARNITINE OCTANOYLTRANSFERASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#1864
20110143959
2011-06-16

COMPOSITIONS AND METHODS FOR DETERMINING THE PROGNOSIS OF BLADDER UROTHELIAL CANCER

#1865
20110143950
2011-06-16

Diagnosis/treatment option for head-and-neck tumor using micro-RNA as biomarker

#1866
20110143357
2011-06-16

System and method for high resolution analysis of nucleic acids to detect sequence variations

#1867
20110142961
2011-06-16

METHODS AND REAGENTS FOR PREDICTING CLINICAL OUTCOME AND CUSTOMIZING CHEMOTHERAPY IN LUNG CANCER PATIENTS

#1868
20110142913
2011-06-16

Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug

#1869
20110142789
2011-06-16

Compositions and Methods for the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis

#1870
20110136836
2011-06-09

Methods for Altering MRNA Splicing and Treating Familial Dysautonomia and Other Mechanistically Related Disorders

#1871
20110136738
2011-06-09

Alternatively Transcribed Genes Associated with Schizophrenia

#1872
20110136685
2011-06-09

METHOD FOR DETERMINING A PREDISPOSITION TO BASAL CELL CARCINOMA AND FOR SCREENING TREATMENTS THEREOF

#1873
20110136246
2011-06-09

Oncogene NRF2

#1874
20110136224
2011-06-09

MDA-7 PROTEINS AND METHODS OF USE THEREOF

#1875
20110136119
2011-06-09

AIMP2-DX2 gene and its uses

#1876
20110135654
2011-06-09

Prostate cancer related gene STYK1

#1877
20110135570
2011-06-09

Anti-Tumor Cell Antigen Antibody Therapeutics

#1878
20110130340
2011-06-02

Methods of identifying anti-cancer agents and uses thereof

#1879
20110130337
2011-06-02

Polymorphisms associated with Parkinson's disease

#1880
20110130335
2011-06-02

THERAPEUTIC AGENT AND TEST AGENT FOR DISEASE WITH MYOCARDIAL NECROSIS

#1881
20110130296
2011-06-02

MULTI-GENE CLASSIFIERS AND PROGNOSTIC INDICATORS FOR CANCERS

#1882
20110129842
2011-06-02

CYANOBACTERIA SAXITOXIN GENE CLUSTER AND DETECTION OF CYANOTOXIC ORGANISMS

#1883
20110129826
2011-06-02

METHOD FOR DETERMINATION OF INFLAMMATORY DISEASE BY USING SINGLE NUCLEOTIDE POLYMORPHISM IN BRCA1-RELATED PROTEIN (BRAP) GENE

#1884
20110129472
2011-06-02

METHODS FOR CONTROLLING VASCULOGENESIS

#1885
20110126302
2011-05-26

Diagnostic and therapeutic methods for EFMR (epilepsy and mental retardation limited to females)

#1886
20110124521
2011-05-26

Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy

#1887
20110123997
2011-05-26

Molecular diagnosis and classification of malignant melanoma

#1888
20110123987
2011-05-26

Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers

#1889
20110123986
2011-05-26

METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

#1890
20110123984
2011-05-26

Method of screening compounds using CALHM (FAM26C)

#1891
20110118313
2011-05-19

IDENTIFICATION OF A MOLECULAR SIGNATURE FOR ANTIPSYCHOTICS AND SERMS

#1892
20110118127
2011-05-19

MARKER GENES FOR SCREENING OF DRUG-INDUCED TOXICITY IN HUMAN CELLS AND SCREENING METHOD USING THE SAME

#1893
20110117572
2011-05-19

Antibody Specific to the AIMP2-DX2

#1894
20110117111
2011-05-19

MICRORNA-BASED DIAGNOSTIC TESTING AND THERAPIES FOR INFLAMMATORY BOWEL DISEASE AND RELATED DISEASES

#1895
20110113498
2011-05-12

SIRT1 POLYMORPHIC VARIANTS AND METHODS OF USE THEREOF

#1896
20110112047
2011-05-12

Methods for enhancing muscle performance and tone

#1897
20110111981
2011-05-12

Method of performing one-step, single cell RT-PCR

#1898
20110111979
2011-05-12

Prostate cancer-related compositions, methods and kits based on DNA microarray proteomics platforms

#1899
20110111966
2011-05-12

Assays for agents affecting megakaryocyte development

#1900
20110111419
2011-05-12

Copy Number Variations Predictive of Risk of Schizophrenia

#1901
20110111417
2011-05-12

METHODS AND KITS FOR MONITORING THE EFFECTS OF IMMUNOMODULATORS ON ADAPTIVE IMMUNITY

#1902
20110111407
2011-05-12

METHOD FOR ANALYSING THE EPIGENETIC STATUS OF THE HTRA 1 GENE IN A BIOLOGICAL SAMPLE

#1903
20110111405
2011-05-12

Novel genes and markers in type 2 diabetes and obesity

#1904
20110111404
2011-05-12

Novel genes and markers in type 2 diabetes and obesity

#1905
20110111396
2011-05-12

BIOMARKERS FOR MONITORING THE TREATMENT BY QUINAZOLINONE COMPOUNDS

#1906
20110111394
2011-05-12

CTGF AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET

#1907
20110110926
2011-05-12

Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants

#1908
20110110925
2011-05-12

Compositions and Methods for the Treatment and Diagnosis of Cancer

#1909
20110110914
2011-05-12

Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers

#1910
20110107440
2011-05-05

SKIN CANCER ASSOCIATED MICRORNAS

#1911
20110105583
2011-05-05

Methods of using MIR34 as a biomarker for TP53 functional status

#1912
20110105365
2011-05-05

PRO-EPIL EXPRESSION LEVEL IN A BIOLOGICAL SAMPLE AS TESTICULAR CANCER BIOMARKER, PARTICULARLY IN COMBINATION WITH THE HCBETA AND AFP BIOMARKERS

#1913
20110104706
2011-05-05

NOVEL KINASES AND USES THEREOF

#1914
20110104680
2011-05-05

RECURRENT GENE FUSIONS IN LUNG CANCER

#1915
20110104674
2011-05-05

SNP DETECTION AND OTHER METHODS FOR CHARACTERIZING AND TREATING BIPOLAR DISORDER AND OTHER AILMENTS

#1916
20110104673
2011-05-05

NUCLEIC ACID SEQUENCES AND METHODS FOR IDENTIFYING COMPOUNDS THAT AFFECT RNA/RNA BINDING PROTEIN INTERACTIONS AND mRNA FUNCTIONALITY

#1917
20110104666
2011-05-05

INSULIN RESISTANCE MARKER

#1918
20110104662
2011-05-05

Methods of Detecting Inhibitors of VIF-Mediated APOBEC3G Degradation and HIV

#1919
20110104306
2011-05-05

Compositions and methods for the identification, assessment, prevention and therapy of human cancers

#1920
20110104136
2011-05-05

Natural killer p30 (NKp30) dysfunction and the biological applications thereof

#1921
20110104065
2011-05-05

Methods of treating pre-malignant ductal cancer with autophagy inhibitors

#1922
20110104059
2011-05-05

Membrane Associated Tumor Endothelium Markers

#1923
20110098341
2011-04-28

USE OF ID4 FOR DIAGNOSIS AND TREATMENT OF CANCER

#1924
20110098191
2011-04-28

IN VITRO METHODS FOR DETECTING RENAL CANCER

#1925
20110097720
2011-04-28

SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS

#1926
20110097711
2011-04-28

Method of judging inflammatory disease by using single nucleotide polymorphism

#1927
20110092572
2011-04-21

Modulation of growth hormone receptor expression and insulin-like growth factor expression

#1928
20110092446
2011-04-21

COMPOSITIONS AND METHODS FOR TREATMENT OF TRAUMA

#1929
20110092390
2011-04-21

ASSESSMENT OF EFFECT OF AN AGENT ON A HUMAN BIOLOGICAL CONDITION USING RODENT GENE EXPRESSION PANELS

#1930
20110091892
2011-04-21

Methods for the diagnosis and treatment of lung cancer

#1931
20110091888
2011-04-21

Cathepsin C-based screening methods for identifying modulators of pain

#1932
20110091482
2011-04-21

EXPRESSION OF KIR IN HUMAN CANCER CELLS AS A BIOMARKER FOR IMMUNO-ESCAPE AND CANCER METASTASIS

#1933
20110091421
2011-04-21

Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases

#1934
20110091381
2011-04-21

GABA biomarkers for depression

#1935
20110086833
2011-04-14

Methods for treating spinal muscular atrophy

#1936
20110086805
2011-04-14

IN VITRO METHOD FOR DIAGNOSING SKIN CANCER

#1937
20110086360
2011-04-14

Method for detection of idiopathic interstitial pneumonia

#1938
20110085982
2011-04-14

DKAT CELL LINE, A MODEL FOR HUMAN TRIPLE-NEGATIVE BREAST CANCER

#1939
20110082284
2011-04-07

Gene overexpressed in cancer

#1940
20110082187
2011-04-07

MARKERS AND METHODS RELATING TO THE ASSESSMENT OF ALZHEIMER'S DISEASE

#1941
20110076303
2011-03-31

Methods for Screening for Anti-Graying Agents on the Basis of AFF-4

#1942
20110076283
2011-03-31

METHOD FOR PREDICTING AND DIAGNOSING BRAIN TUMOR

#1943
20110076280
2011-03-31

DKK1 oncogene as therapeutic target for cancer and a diagnosing marker

#1944
20110076274
2011-03-31

MATERIALS AND METHODS RELATING TO A G-PROTEIN COUPLED RECEPTOR

#1945
20110071032
2011-03-24

Novel tumor marker determination

#1946
20110070652
2011-03-24

Phage microarray profiling of the humoral response to disease

#1947
20110070245
2011-03-24

IMP-1 ONCOGENE AS A THERAPEUTIC TARGET AND PROGNOSTIC INDICATOR FOR LUNG CANCER

#1948
20110070221
2011-03-24

mutations in melanoma

#1949
20110067123
2011-03-17

MAO-B ELEVATION AS AN EARLY PARKINSON'S DISEASE BIOMARKER

#1950
20110065113
2011-03-17

Recurrent gene fusions in prostate cancer

#1951
20110065102
2011-03-17

OSTEOARTHRITIS-SENSITIVE GENE

#1952
20110065100
2011-03-17

Transcription biomarkers of biological responses and methods

#1953
20110064747
2011-03-17

METHODS FOR TREATMENT OF A SARCOMA USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)

#1954
20110064739
2011-03-17

MEDICAMENT, COMPOSITIONS, AND SUBSTANCES FOR TREATING AND IDENTIFYING ADENOCARCINOMA OF THE LUNG

#1955
20110064730
2011-03-17

METHOD OF MODULATING ANGIOGENESIS

#1956
20110064722
2011-03-17

Modulators of alpha-synuclein toxicity

#1957
20110064659
2011-03-17

GLUTAMINE BIOMARKERS FOR DEPRESSION

#1958
20110064655
2011-03-17

BIOMARKERS FOR DEPRESSION

#1959
20110059900
2011-03-10

Diagnosing and treating hormone resistant cancers

#1960
20110059899
2011-03-10

Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein

#1961
20110059434
2011-03-10

P13K pathway mutations in cancer

#1962
20110059113
2011-03-10

GAB2 AMPLIFICATION IN MELANOMA

#1963
20110059066
2011-03-10

PAKs as Modifiers of the CHK Pathway and Methods of Use

#1964
20110054009
2011-03-03

MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders

#1965
20110053281
2011-03-03

Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition

#1966
20110053164
2011-03-03

Methods for determining cancer resistance to histone deacetylase inhibitors

#1967
20110052570
2011-03-03

METHOD TO PROGNOSE RESPONSE TO ANTI-EGFR THERAPEUTICS

#1968
20110052502
2011-03-03

MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof

#1969
20110047634
2011-02-24

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA

#1970
20110046094
2011-02-24

METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING LUPUS

#1971
20110045999
2011-02-24

Identification of novel subgroups of high-risk pediatric precursor B acute lymphoblastic leukemia, outcome correlations and diagnostic and therapeutic methods related to same

#1972
20110045998
2011-02-24

CANDIDATE GENES AND BLOOD BIOMARKERS FOR BIPOLAR MOOD DISORDER, ALCOHOLISM AND STRESS DISORDER

#1973
20110045501
2011-02-24

ST2-BASED DENGUE FEVER DIAGNOSTIC

#1974
20110045471
2011-02-24

Methods for Assaying MC1R Variants and Mitochondrial Markers in Skin Samples

#1975
20110045053
2011-02-24

ISOLATED POPULATION OF LUMINAL STEM CELLS THAT GIVE RISE TO PROSTATE CANCER AND METHODS OF USING SAME

#1976
20110045020
2011-02-24

Nucleic acid comprising chimeric gene derived from hepatitis C virus

#1977
20110039788
2011-02-17

COMPOSITIONS, METHODS AND KITS FOR DETECTING AND TREATING CANCER

#1978
20110038944
2011-02-17

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF HEPATOBILIARY DISEASE AND ASSOCIATED DISORDERS

#1979
20110035818
2011-02-10

DIAGNOSTIC MARKER AND PLATFORM FOR DRUG DESIGN IN MYOCARDIAL INFARCTION AND HEART FAILURE

#1980
20110035814
2011-02-10

COOPERATING ONCOGENES IN CANCER

#1981
20110034677
2011-02-10

Recurrent gene fusions in prostate cancer

#1982
20110034538
2011-02-10

MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Gastric Cancer

#1983
20110034533
2011-02-10

Compositions and methods modulating MG29 for the treatment of diabetes

#1984
20110033873
2011-02-10

Proteinic marker for early diagnosis of liver cancer

#1985
20110033850
2011-02-10

COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION

#1986
20110033466
2011-02-10

HUMAN TRANSCRIPTOMES

#1987
20110033444
2011-02-10

Genetic variants in a hypertension susceptibility gene Stk39 and uses thereof

#1988
20110030070
2011-02-03

Diagnosis and treatment of autism using CD38

#1989
20110028470
2011-02-03

Detection and treatment of schizophrenia

#1990
20110028336
2011-02-03

MIPOL1-ETV1 gene rearrangements

#1991
20110027882
2011-02-03

Methods and Compositions for Treating Neurological Disease

#1992
20110027814
2011-02-03

BRCA1 function-based cellular assays

#1993
20110027806
2011-02-03

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

#1994
20110027289
2011-02-03

Method for treating synovial sarcoma

#1995
20110027247
2011-02-03

METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)

#1996
20110027173
2011-02-03

Methods for treating cancer using ephrin type-A receptor 10 antibodies conjugated to cytotoxic agents

#1997
20110021609
2011-01-27

MicroRNA Signatures Associated with Cytogenetics and Prognosis in Acute Myeloid Leukemia (AML) and Uses Thereof

#1998
20110021607
2011-01-27

Methods and Compositions Relating to Carcinoma Stem Cells

#1999
20110020826
2011-01-27

Methods for assessing efficacy of chemotherapeutic agents

#2000
20110020810
2011-01-27

TRPC6 involved in glomerulonephritis

#2001
20110020809
2011-01-27

Method of diagnosing mild osteoarthritis

#2002
20110020801
2011-01-27

Carboxylesterase-1 Polymorphisms and Methods of Use Therefor

#2003
20110020799
2011-01-27

Screening method for damaged DNA repairing substance

#2004
20110020365
2011-01-27

Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma

#2005
20110020320
2011-01-27

Genetic Variants Contributing to Risk of Prostate Cancer

#2006
20110020317
2011-01-27

BREAST TUMOUR GRADING

#2007
20110020312
2011-01-27

METHODS FOR TREATMENT OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

#2008
20110020230
2011-01-27

BIOMARKERS FOR PROSTATE CANCER

#2009
20110015092
2011-01-20

Markers for breast cancer

#2010
20110015090
2011-01-20

Ex vivo methods for targeting or depleting acute myeloid leukemia cancer stem cells

#2011
20110014615
2011-01-20

METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCERS BY tRNA-DIHYDROURIDINE SYNTHASE ACTIVITY OF URLC8

#2012
20110014610
2011-01-20

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING NEUROPSYCHIATRIC DISORDERS

#2013
20110014603
2011-01-20

Targets for use in diagnosis, prognosis and therapy of cancer

#2014
20110014602
2011-01-20

Diagnostic composition for hepatocellular carcinoma, a diagnostic kit comprising it and diagnostic methods of hepatocellular carcinoma

#2015
20110014214
2011-01-20

Diagnostic and Therapeutic Utility of Tribbles-2 in Human Cancers

#2016
20110014205
2011-01-20

Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A

#2017
20110014204
2011-01-20

Cancer Chemoprevention Strategy Based on Loss of Imprinting of IGF2

#2018
20110014191
2011-01-20

BREAST CANCER EXPRESSION PROFILING

#2019
20110014183
2011-01-20

MCAM modulation and uses thereof

#2020
20110010780
2011-01-13

KCNN3 AS DIAGNOSTIC AND THERAPEUTIC TARGET FOR NEURODEGENERATIVE DISEASES

#2021
20110009476
2011-01-13

Transcription factor decoys, compositions and methods

#2022
20110009469
2011-01-13

COMPOSITIONS AND METHODS OF TREATING NEOPLASIA

#2023
20110009467
2011-01-13

Methods to increase or decrease bone density

#2024
20110008393
2011-01-13

NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 58P1D12 USEFUL IN TREATMENT AND DETECTION OF CANCER

#2025
20110008370
2011-01-13

Use of FLJ25416 gene

#2026
20110008346
2011-01-13

BIOMARKERS FOR CARDIOVASCULAR DISEASE

#2027
20110008320
2011-01-13

Further Use of Protein Kinase N Beta

#2028
20110002940
2011-01-06

PATHWAYS INVOLVED IN ARTERIOGENESIS AND USES THEREOF

#2029
20100330558
2010-12-30

Gene Expression Profiling for Identification, Monitoring and Treatment of Cervical Cancer

#2030
20100323908
2010-12-23

Methods and compositions for diagnosing osteoarthritis in a feline

#2031
20100323357
2010-12-23

MicroRNA Expression Profiling and Targeting in Peripheral Blood in Lung Cancer

#2032
20100323347
2010-12-23

Method for evaluating or selecting agent for preventing or curing photodamage of skin

#2033
20100323346
2010-12-23

Method of examining inflammatory disease and method of screening remedy for inflammatory disease

#2034
20100317726
2010-12-16

SLCO1B3 genotype

#2035
20100317003
2010-12-16

NOVEL COMPOSITIONS AND METHODS IN CANCER WITH ALTERED EXPRESSION OF KCNJ9

#2036
20100316994
2010-12-16

Diagnosis and therapy of cancer using SGP28-related molecules

#2037
20100311822
2010-12-09

ACE2 activation for treatment of heart, lung and kidney disease and hypertension

#2038
20100311815
2010-12-09

MIR-101 CANCER MARKERS

#2039
20100311053
2010-12-09

USE OF CLEC1B FOR THE DETERMINATION OF CARDIOVASCULAR AND THROMBOTIC RISK

#2040
20100311047
2010-12-09

Identification of cancer protein biomarkers using proteomic techniques

#2041
20100311045
2010-12-09

CANCER

#2042
20100311044
2010-12-09

ASSAY KIT FOR IN-SITU HYBRIDIZATION OF RHOGDI2 GENE, METHOD THEREFOR AND USE THEREOF THE ASSAY KIT

#2043
20100310578
2010-12-09

Lipocalin-2 antibodies for methods of treatment

#2044
20100310568
2010-12-09

Ninjurin-1 modulation and uses thereof

#2045
20100304984
2010-12-02

PREDICTION OF POTENTIAL DRUG-DRUG INTERACTIONS USING GENE EXPRESSION PROFILING OF DRUG TRANSPORTERS, CYTOCHROME P450S AND NUCLEAR X RECEPTORS

#2046
20100298438
2010-11-25

Gene expression profiling of Parkinson's Disease

#2047
20100298434
2010-11-25

NEUROPROTECTION AND PREVENTION OF DOPAMINERGIC CELL DEATH BY TARGETING NUR77 TRANSLOCATION

#2048
20100298404
2010-11-25

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#2049
20100298158
2010-11-25

Compositions, Kits, and Methods for Identification, Assessment, Prevention, and Therapy of Cancer

#2050
20100297657
2010-11-25

EXPRESSION PROFILE OF PROSTATE CANCER

#2051
20100297650
2010-11-25

Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer

#2052
20100297619
2010-11-25

GENETIC PREDICTION OF SCHIZOPHRENIA SUSCEPTIBILITY

#2053
20100297615
2010-11-25

EGFR mutations

#2054
20100297152
2010-11-25

METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF SCREENING FOR MODULATORS OF PROSTATE CANCER

#2055
20100297149
2010-11-25

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

#2056
20100292308
2010-11-18

MicroRNA molecules

#2057
20100292162
2010-11-18

SOCS-3 promoter methylation in cancer

#2058
20100292159
2010-11-18

Method of treatment or prophylaxis of inflammatory pain

#2059
20100291590
2010-11-18

Methods for the diagnosis and the prognosis of a brain tumor

#2060
20100291551
2010-11-18

GENEMAP OF THE HUMAN ASSOCIATED WITH CROHN'S DISEASE

#2061
20100291550
2010-11-18

Methods and compositions for modulating hair growth

#2062
20100291099
2010-11-18

NOVEL 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 AND 32222 MOLECULES AND USES THEREFOR

#2063
20100291091
2010-11-18

CANCER ASSOCIATED GENE LY6K

#2064
20100291068
2010-11-18

NUCLEIC ACID MOLECULES AND PROTEINS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF OVARIAN CANCER

#2065
20100291032
2010-11-18

COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION

#2066
20100287631
2010-11-11

WNT PATHWAY MUTATIONS IN CANCER STEM CELLS

#2067
20100286262
2010-11-11

PTGS2 HAPLOTYPES

#2068
20100286249
2010-11-11

Micro-RNAs modulating immunity and inflammation

#2069
20100286246
2010-11-11

Identification of novel genes coding for small temporal RNAS

#2070
20100286245
2010-11-11

Identification of novel genes coding for small temporal RNAs

#2071
20100286237
2010-11-11

Pro-angiogenic genes in ovarian tumor endothelial cell isolates

#2072
20100286232
2010-11-11

MICRORNA EXPRESSION PROFILE ASSOCIATED WITH PANCREATIC CANCER

#2073
20100286231
2010-11-11

METHOD FOR IDENTIFYING A RENAL FIBROSIS PROCESS USE OF SNAIL- ACTIVITY-INHIBITING COMPOUNDS IN THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS, METHOD FOR IDENTIFYING SAID INHIBITING COMPOUNDS, SAID PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS THEREOF

#2074
20100285995
2010-11-11

Identification and Characterization of Pregnancy-Associated Genetic Signatures and Use Thereof for Diagnosis and Treatment of Breast Cancer

#2075
20100285979
2010-11-11

Diagnostic tool for diagnosing benign versus malignant thyroid lesions

#2076
20100285580
2010-11-11

Cardiac Conduction System (CCS) Progenitor Cells and Uses Thereof

#2077
20100285462
2010-11-11

Methods and materials related to grey alleles

#2078
20100285458
2010-11-11

Gene Expression Profiling for Identification, Monitoring, and Treatment of Lupus Erythematosus

#2079
20100284991
2010-11-11

Methods for the Treatment and Diagnosis of Bone Mineral Density Related Diseases

#2080
20100284989
2010-11-11

15-PGDH in colon cancer

#2081
20100284915
2010-11-11

GENES ASSOCIATED WITH CHEMOTHERAPY RESPONSE AND USES THEREOF

#2082
20100280104
2010-11-04

METHODS AND KITS FOR DIAGNOSIS AND TREATMENT OF CELL-CELL JUNCTION RELATED DISORDERS

#2083
20100280084
2010-11-04

Cyp1B1 Genotype

#2084
20100280060
2010-11-04

Methods of screening and compositions for life span modulators

#2085
20100279301
2010-11-04

METHODS AND COMPOSITIONS FOR DIAGNOSING BLADDER CANCER

#2086
20100279300
2010-11-04

METHODS FOR DETERMINING THE PROGNOSIS FOR PATIENTS WITH A PROSTATE NEOPLASTIC CONDITION

#2087
20100279296
2010-11-04

Enhanced FC receptor-mediated tumor necrosis factor superfamily MRNA expression in peripheral blood leukocytes in patients with rheumatoid arthritis

#2088
20100273995
2010-10-28

Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin B and related compounds

#2089
20100273663
2010-10-28

Methods and compositions related to arrhythmogenic right ventricular cardiomyopathy (ARVC)

#2090
20100273658
2010-10-28

Methods of isolating methylated CpG islands

#2091
20100273153
2010-10-28

GENETIC DIAGNOSIS OF DEPRESSION

#2092
20100267810
2010-10-21

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE

#2093
20100267576
2010-10-21

Compositions And Methods For Identifying And Treating Subjects At Risk Of Developing Type 2 Diabetes

#2094
20100267052
2010-10-21

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES

#2095
20100267028
2010-10-21

TGFBR1 expression modifies risk for colorectal cancer

#2096
20100267025
2010-10-21

METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF CARDIOVASCULAR FUNCTION AND DISORDERS

#2097
20100266588
2010-10-21

Breast Cancer Susceptibility Gene GT198 and Uses Thereof

#2098
20100266569
2010-10-21

PROSTATIC ACID PHOSPHATASE FOR THE TREATMENT OF PAIN

#2099
20100266555
2010-10-21

MICRO RNAS AS MARKERS OF THE FUNCTIONAL STATE OF A DENDRITIC CELL

#2100
20100261778
2010-10-14

Tumor Suppressor Killin